Fanni Gergely elected to EMBO Membership
Dr Fanni Gergely, Senior Group Leader at the Institute, has been elected as a member of the European Molecular Biology Organisation (EMBO) in recognition of her high quality life science research.
Fanni is one of 56 new members who are joining more than 1800 of the best researchers in Europe and around the world.
Election to EMBO Membership is recognition of research excellence and the outstanding achievements made by a life scientist. EMBO Members actively participate in the execution of the organisation’s initiatives by serving on Council, committees and editorial boards, and by evaluating applications for EMBO funding. As a result, EMBO Members collectively influence the future directions of life science research and strengthen research communities across Europe.
It is an honour to be elected a member of EMBO. This award also recognises the research efforts of my talented team and fantastic collaborators
Dr Fanni Gergely, Cancer Research UK Cambridge Institute
Fanni’s research seeks to understand how centrosomes contribute to normal and pathological processes such as embryonic growth, neurodevelopment and tumourigenesis. By using a combination of genetic, molecular and proteomic tools, her team interrogates the roles of centrosome components in cell proliferation and signalling. Most recently, the group’s work is focused on identifying tissue-specific functions for these ubiquitous organelles.
“It is an honour to be elected a member of EMBO by my peers. This award also recognises the research efforts of my talented team and fantastic collaborators, all made possible by the invaluable support of Cancer Research UK and the Cambridge Institute” says Fanni. “I look forward to contributing to EMBO’s valuable work strengthening the research community in Europe and beyond.”
EMBO Members are excellent scientists who conduct research at the forefront of all life science disciplines
Maria Leptin, EMBO Director
“EMBO Members are excellent scientists who conduct research at the forefront of all life science disciplines, ranging from computational models or analyses of single molecules and cellular mechanics to the study of higher-order systems in development, cognitive neuroscience and evolution,” says EMBO Director Maria Leptin.
The new EMBO Members and Associate Members will be formally welcomed at the annual Members’ Meeting in Heidelberg between 29 and 31 October 2019.
Read more
Cambridge scientists recognised by major European research organisation
Related News
See all news-
Imaging technique allows rapid assessment of ovarian cancer subtypes and their response to treatment
6th December 2024
An MRI-based imaging technique developed at the Institute predicts the response of ovarian cancer tumours to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models.
Find out more -
Isabel Esain Garcia awarded PhD Thesis Prize
3rd December 2024
The Prize is awarded annually to a student who has undertaken an outstanding research project to the highest standards during the course of their PhD study at the Cancer Research UK Cambridge Institute.
Find out more -
World first trial to revolutionise treatment of brain cancer
23rd October 2024
A pioneering research study will trial multiple new treatments for people in the UK living with glioblastoma, an aggressive form of brain cancer.
Find out more